The study researchers, published in JAMA, found that aspirin or NSAIDS was associated with a lower CRC risk in the majority of the cohort, but those with a rare genotype who used aspirin had an increased risk of CRC. Four percent to 5 percent of the cohort had the rare genotype.
More articles on gastroenterology:
Dr. Carol Morris joins Bayhealth Gastroenterology
Olympus faces 5 lawsuits in wake of UCLA outbreak
Check-Cap IPO unites to trade separately from March 18 onwards
